Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Seal · SciRah

Researcher profile · Semantic Scholar

B. Seal

Share profile

B. Seal — researcher profile on SciRah

h-index: 23
Works: 271
Citations: 3,159

Most-cited papers

Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.
A. Ganti, A. Klein, I. Cotarla, B. Seal +1 more
2021JAMA Oncology707 citations Open access
Semantic Scholar
Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer
B. Seal, S. Anderson, K. Shermock
2016Journal of Managed Care & Specialty Pharmacy40 citations Open access
Semantic Scholar
Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis
R. Hansen, Yi-Duo Zhang, B. Seal, K. Ryan +3 more
2019BMC Cancer38 citations Open access
Semantic Scholar
Algorithm for Identifying Chemotherapy/Biological Regimens for Metastatic Colon Cancer in SEER-Medicare
Kaloyan A. Bikov, C. Mullins, B. Seal, E. Onukwugha +1 more
2015Medical Care34 citations
Semantic Scholar
Evaluation of Healthcare Interventions and Big Data: Review of Associated Data Issues
C. Asche, B. Seal, K. Kahler, E. Oehrlein +1 more
2017PharmacoEconomics (Auckland)28 citations
Semantic Scholar
Disease burden of systemic light-chain amyloidosis: a systematic literature review
H. Lin, Xin Gao, C. Cooke, D. Berg +4 more
2017Current Medical Research and Opinion28 citations
Semantic Scholar
Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States
Ravi K. Goyal, S. Nagar, Shaum M. Kabadi, J. Kaye +2 more
2018Leukemia and Lymphoma21 citations Open access
Semantic Scholar
Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting
A. Aly, N. Fulcher, B. Seal, T. Pham +3 more
2023Hepatic Oncology20 citations Open access
Semantic Scholar
Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study
P. Bröckelmann, E. Zagadailov, S. Corman, Viktor Chirikov +5 more
2017European Journal of Haematology20 citations Open access
Semantic Scholar
Real-world effectiveness of brentuximab vedotin versus physicians’ choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany
E. Zagadailov, S. Corman, Viktor Chirikov, Courtney Johnson +5 more
2018Leukemia and Lymphoma19 citations Open access
Semantic Scholar
Cost-Effectiveness of Durvalumab After Chemoradiotherapy in Unresectable Stage III NSCLC: A US Healthcare Perspective.
R. Mehra, Candice Yong, B. Seal, M. van Keep +2 more
2021The Journal of the National Comprehensive Cancer Network17 citations Open access
Semantic Scholar
Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment
Candice Yong, M. J. Cambron-Mellott, B. Seal, O. Will +5 more
2022Patient Preference and Adherence15 citations Open access
Semantic Scholar
Multispecialist Care and Mortality in Hepatocellular Carcinoma
V. Chirikov, C. Mullins, N. Hanna, Ian M. Breunig +2 more
2015American Journal of Clinical Oncology15 citations
Semantic Scholar
Real-world incidence and cost of pneumonitis post-chemoradiotherapy for stage III non-small-cell lung cancer.
K. Ryan, D. Nero, B. Feinberg, C. H. Lee +4 more
2019Future Oncology10 citations Open access
Semantic Scholar
Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USA
M. Healey, B. Seal, N. Princic, D. Black +3 more
2022Advances in Therapy9 citations Open access
Semantic Scholar
Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007–2018
V. Shankaran, S. Chennupati, Hayley Sanchez, Qin Sun +5 more
2021Journal of Hepatocellular Carcinoma9 citations Open access
Semantic Scholar
Patterns of Biologics Use Across Treatment Lines in Elderly (Age >65) Medicare Patients With Metastatic Colon Cancer.
K. Bikov, C. Mullins, Anna Hung, B. Seal +2 more
2016The Oncologist9 citations Open access
Semantic Scholar
Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer
Anna Hung, K. Lee, J. Lynch, Yan-Hong Li +8 more
2021BMC Cancer8 citations Open access
Semantic Scholar
The Cost of Absenteeism and Short-Term Disability Associated With Colorectal Cancer: A Case–Control Study
A. Yaldo, B. Seal, M. Lage
2014Journal of Occupational and Environmental Medicine7 citations
Semantic Scholar
Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study
L. Lal, A. Aly, L. Le, Susan Peckous +2 more
2021Cancer Reports6 citations Open access
Semantic Scholar
Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting.
B. Seal, S. Sullivan, S. Ramsey, C. Asche +5 more
2015Future Oncology6 citations
Semantic Scholar
Specialist visits and initiation of cancer-directed treatment among a large cohort of men diagnosed with prostate cancer.
E. Onukwugha, Candice Yong, M. Naslund, C. Woods +3 more
2017Urologic oncology5 citations
Semantic Scholar
Association Between Treatment Regimen Type in Second-Line Therapy (2LT) and Duration of Therapy (DOT) & Time To Next Treatment (TTNT) in a United States (US) Relapsed/Refractory Multiple Myeloma (RRMM) Cohort
D. Romanus, A. Raju, Candice Yong, E. Farrelly +6 more
20175 citations
Semantic Scholar
Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA
A. Aly, M. Lingohr-Smith, Jay Lin, B. Seal
2021Hepatic Oncology4 citations Open access
Semantic Scholar
Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone
E. Onukwugha, Y. Kwok, J. Ciezki, Candice Yong +6 more
2017PLoS ONE4 citations Open access
Semantic Scholar
KRAS tests utilizations, biologics uptakes, and disparities in access by demographic groups among metastatic colon cancer patients.
D. Goto, C. Mullins, K. Bikov, B. Seal +1 more
20154 citations
Semantic Scholar
Management of hepatocellular carcinoma from diagnosis in routine clinical practice
T. Lokhandwala, A. Aly, E. Farrelly, J. Willey +4 more
2022Hepatic Oncology3 citations Open access
Semantic Scholar
Durvalumab consolidation therapy following chemoradiotherapy among patients with unresectable stage III non-small cell lung cancer (NSCLC) treated in a U.S. community oncology network.
D. Waterhouse, Candice Yong, N. Robert, K. Aguilar +4 more
2021Journal of Clinical Oncology2 citations
Semantic Scholar
Real‐world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno‐oncology therapy
R. Mehra, Huan Huang, B. Seal, J. Tse +2 more
2020Head and Neck2 citations
Semantic Scholar
Patient and caregiver benefit-risk preferences for treatment in advanced urothelial carcinoma.
A. Apolo, M. J. Cambron-Mellott, O. Will, B. Seal +5 more
20202 citations
Semantic Scholar
Treatment patterns in extensive-stage small cell lung cancer: A retrospective real-world data study.
A. Ganti, K. Katranji, B. Seal, L. Brannman
20202 citations
Semantic Scholar
Treatment Patterns and Clinical Outcomes Among Patients with Newly Diagnosed and Relapsed/Refractory Systemic Light Chain Amyloidosis
H. Lin, C. Asche, Jin-Ma Ren, Candice Yong +4 more
20162 citations
Semantic Scholar
Evaluating the Cost of Treating Bladder Cancer With and Without Metastases
B. Seal, K. Shermock, C. Asche, Jane Chang +6 more
20152 citations Open access
Semantic Scholar
Idelalisib Plus Rituximab Versus Placebo Plus Rituximab For Relapsed Chronic Lymphocytic Leukemia: A Cost-Effectiveness Analysis
J.-S. Yu, B. Seal, J. Carlson
20152 citations Open access
Semantic Scholar
Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology Practices
A. Klink, L. Marshall, A. Aly, B. Seal +2 more
2022The Oncologist1 citations Open access
Semantic Scholar
Healthcare utilization and costs in hepatocellular carcinoma (HCC) patients treated at a large referral center in Washington (WA) State.
V. Shankaran, S. Chennupati, Hayley Sanchez, Qin Sun +3 more
20211 citations
Semantic Scholar
Concordance of provider treatment patterns with NCCN oncology treatment guidelines (NCCN Guidelines) for metastatic non-small cell lung cancer (mNSCLC).
B. Seal, M. Mooradian, Candice Yong, A. Schroeder +3 more
20201 citations
Semantic Scholar
Medical oncologists’ first-line treatment preferences in metastatic urothelial carcinoma.
A. Apolo, M. J. Cambron-Mellott, K. Beusterien, B. Seal +5 more
20201 citations
Semantic Scholar
Concurrent and sequential chemoradiation therapy are associated with improved survival among unresected stage III non-small cell lung cancer patients in the United States.
Zhi-Yuan Zheng, R. Rengan, Jing-Xuan Zhao, Helmneh M. Sineshaw +6 more
20201 citations
Semantic Scholar
An Approach to Identify Delivery of Palliative Radiation Therapy Using Health Care Claims Data: A Proof-of-Concept Application of a Visual Analytics Tool.
E. Onukwugha, Jinani C. Jayasekera, J. Gardner, Sana Malik +7 more
2018JCO Clinical Cancer Informatics1 citations Open access
Semantic Scholar
Treatment (tx) Patterns & Outcomes by Line of Therapy (LOT) in a Large United States (US) Cohort of Transplant-Ineligible Patients (pts) with Multiple Myeloma in the Era of Novel Agents
D. Romanus, A. Raju, B. Seal, E. Farrelly +3 more
20171 citations
Semantic Scholar
Treatment patterns among patients with higher-risk myelodysplastic syndromes in a real-world setting: Electronic medical record (EMR)-based data.
B. Dezube, J. Bell, A. Galaznik, E. Farrelly +4 more
20171 citations
Semantic Scholar
A Real-World Evidence Systematic Literature Review of Health-Related Quality of Life, Costs and Economic Evaluations in Newly-Diagnosed Multiple Myeloma Patients
Candice Yong, E. Korol, Zaeem Khan, H. Lin +4 more
20161 citations
Semantic Scholar
Real-World Treatment Patterns and Health Care Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Cohort Review in France
H. Lin, K. Davis, J. Kaye, K. Luptakova +4 more
20161 citations
Semantic Scholar
Systematic Review of Therapy Used in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
A. Galaznik, J. Bell, Meredith M. Hoog, M. Stokes +4 more
20161 citations
Semantic Scholar
Brentuximab vedotin in patients who are ineligible for autologous stem cell transplant with relapsed or refractory Hodgkin lymphoma: a United Kingdom and Germany retrospective study.
P. Bröckelmann, E. Zagadailov, S. Corman, M. Hagan +6 more
20161 citations
Semantic Scholar
Cost of Care for Gastric Cancer In Patients With and Without Metastases
K. Shermock, C. Asche, B. Seal, C. Kreilick +5 more
20151 citations Open access
Semantic Scholar
THE IMPLICATIONS OF USING A 30-, 60-, OR 90-DAY GAP IN TREATMENT TO SPECIFY LINES OF CARE IN GASTRIC CANCER TREATMENT
B. Seal, K. Shermock, C. Asche, C. Kreilick +4 more
20151 citations Open access
Semantic Scholar
Impact of skeletal-related events on survival in patients with prostate cancer metastatic to bones.
J. McDougall, B. Goulart, S. Sullivan, J. McCune +6 more
20151 citations
Semantic Scholar
OFP01.09 Economic Burden of Metastatic Non-Small Cell Lung Cancer (mNSCLC) in a Large United States (US) Claims Database
E. Chou, A. Ganti, K. Katranji, I. Cotarla +4 more
20210 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Candice Yong×12
Invite
Candice Yong — researcher profile on SciRah
A. Aly×7
Invite
A. Aly — researcher profile on SciRah
E. Zagadailov×7
Invite
E. Zagadailov — researcher profile on SciRah
C. Asche×6
Invite
C. Asche — researcher profile on SciRah

×5

Invite

K. Shermock — researcher profile on SciRah

E. Onukwugha×5

Invite

E. Onukwugha — researcher profile on SciRah

Invite

E. Farrelly — researcher profile on SciRah

Invite

I. Cotarla — researcher profile on SciRah

Invite

N. Hanna — researcher profile on SciRah

Invite

H. Lin — researcher profile on SciRah

Invite

C. Mullins — researcher profile on SciRah

K. Luptakova×4

Invite

K. Luptakova — researcher profile on SciRah